Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-17.63M
↑ 29% vs avg
Percentile
P78
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-24.95M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-17.63M | +71.1% |
| 2024 | $-60.95M | -56.5% |
| 2023 | $-38.94M | -105.5% |
| 2022 | $-18.95M | +33.4% |
| 2021 | $-28.46M | +10.1% |
| 2020 | $-31.68M | -12.8% |
| 2019 | $-28.09M | -50.6% |
| 2018 | $-18.65M | -306.9% |
| 2017 | $-4.58M | -184.5% |
| 2016 | $-1.61M | - |